160 related articles for article (PubMed ID: 29931295)
1. Prognostic factors of non-ampullary duodenal adenocarcinoma.
Hirashita T; Ohta M; Tada K; Saga K; Takayama H; Endo Y; Uchida H; Iwashita Y; Inomata M
Jpn J Clin Oncol; 2018 Aug; 48(8):743-747. PubMed ID: 29931295
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes.
Tesarikova J; Skalicky P; Kurfurstova D; Svebisova H; Urban O; Falt P; Zapletalova J; Klos D; Lovecek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):290-296. PubMed ID: 34012147
[TBL] [Abstract][Full Text] [Related]
3. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
6. Pathologic T1 subclassification of ampullary carcinoma with perisphincteric or duodenal submucosal invasion: Is it T1b?
You D; Heo J; Choi S; Choi D; Jang KT
Arch Pathol Lab Med; 2014 Aug; 138(8):1072-6. PubMed ID: 25076296
[TBL] [Abstract][Full Text] [Related]
7. Surgical Strategy for T1 Duodenal or Ampullary Carcinoma According to the Depth of Tumor Invasion.
Kohga A; Yamamoto Y; Sano S; Sugiura T; Okamura Y; Ito T; Ashida R; Ishiwatari H; Matsubayashi H; Sasaki K; Uesaka K
Anticancer Res; 2017 Sep; 37(9):5277-5283. PubMed ID: 28870965
[TBL] [Abstract][Full Text] [Related]
8. Can endoscopic papillectomy be curative for early ampullary adenocarcinoma of the ampulla of Vater?
Alvarez-Sanchez MV; Oria I; Luna OB; Pialat J; Gincul R; Lefort C; Bourdariat R; Fumex F; Lepilliez V; Scoazec JY; Salgado-Barreira A; Lemaistre AI; Napoléon B
Surg Endosc; 2017 Apr; 31(4):1564-1572. PubMed ID: 27530895
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Intra-Ampullary Papillary-Tubular Neoplasm versus Flat Dysplasia as Precursor Lesions of Ampullary Adenocarcinoma.
Han S; Jang KT; Choi DW; Choi SH; Heo JS; Han IW; Park D; Ryu Y
Dig Surg; 2020; 37(6):505-514. PubMed ID: 33080609
[TBL] [Abstract][Full Text] [Related]
10. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.
Wu CL; Chao YJ; Yang TM; Chen YL; Chang KC; Hsu HP; Shan YS; Lai MD
BMC Cancer; 2015 Nov; 15():903. PubMed ID: 26572077
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.
Vilhordo DW; Gregório C; Valentini DF; Edelweiss MIA; Uchoa DM; Osvaldt AB
J Gastrointest Cancer; 2021 Sep; 52(3):872-881. PubMed ID: 32808236
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
14. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
[TBL] [Abstract][Full Text] [Related]
15. Transduodenal local resection for low-risk group ampulla of vater carcinoma.
Park JS; Yoon DS; Park YN; Lee WJ; Chi HS; Kim BR
J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):737-42. PubMed ID: 18158802
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing lymph node metastasis in patients with ampullary adenocarcinoma.
Okano K; Asano E; Kushida Y; Kamada H; Mori H; Suzuki Y
Dig Surg; 2014; 31(6):459-67. PubMed ID: 25613423
[TBL] [Abstract][Full Text] [Related]
17. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery.
Uchida H; Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
Hepatogastroenterology; 2009; 56(93):1194-8. PubMed ID: 19760968
[TBL] [Abstract][Full Text] [Related]
18. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological differences of sporadic non-ampullary duodenal epithelial neoplasm depending on tumor location.
Matsueda K; Kanzaki H; Matsueda K; Nasu J; Yoshioka M; Nakagawa M; Inoue M; Inaba T; Imagawa A; Takatani M; Takenaka R; Suzuki S; Tomoda J; Yagi T; Fujiwara T; Tanaka T; Okada H
J Gastroenterol Hepatol; 2019 Sep; 34(9):1540-1544. PubMed ID: 30812050
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
